Home
Live Updates
Modernas new COVID-19 vaccine shows promising results in Phase 3 trial, company says : comparemela.com
Moderna's new COVID-19 vaccine shows promising results in Phase 3 trial, company says
Moderna has announced that its next-generation COVID-19 vaccine, mRNA-1283, has successfully met the primary endpoints of its Phase 3 clinical trial.
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Canada ,
,
United States ,
Health Medical Pharma ,
Moderna ,
Bancel ,
Nc ,
Business Finance ,
Mrna Vaccine ,
Rna Vaccines ,
Pfizer Biontech Covid 19 Vaccine ,
Vaccine ,
Covid 19 Vaccination In The United States ,
Moderna Covid 19 Vaccine ,
Deployment Of Covid 19 Vaccines ,
Covid 19 Pandemic By Country ,
Covid 19 Vaccination In Canada ,
Covid 19 Vaccine ,
Mrna 1283 ,
comparemela.com © 2020. All Rights Reserved.